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Letter to the Editor
Introduction
Lung cancer remains a condition that is frequently diagnosed too 
late for optimum prognosis [1].  Several factors seem to contribute 
to this, but there is good evidence that response to potential 
symptoms of lung cancer and awareness of the condition varies 
between men and women. This is believed to contribute to delayed 
diagnosis in men, with reluctance to report minor symptoms to a 
general medical practitioner (GP) identified as one cause [2].  In 
response to this, audit data from a two week health improvement 
campaign undertaken by 29 pharmacies in North West London 
during Lung Cancer Awareness Month in 2013, was subjected to 
analysis that included gender as a variable. The results suggest that 
this analysis was justified. 
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Methods
Following Royal Pharmaceutical Society guidance, an audit pack 
was devised by a team of pharmacists who subsequently collated 
the results from all pharmacies. Pharmacy staff anonymously 
interviewed adult patients who asked one of four relevant questions 
retrieved from a counter aid, modified for the study. The questions 
related to respiratory symptoms including sore throat, cough and 
chest pain, or a wish to discuss smoking cessation. The results were 
examined and subjected to simple analysis to determine whether 
there was any association between in-pharmacy outcomes and 
recorded variables. 
Results
From the 267 interviews, a sub-group of 109 patients was identified, 
who complained of a persistent cough lasting more than 3 weeks 
that was not obviously linked to some short-term cause. The 
demographic characteristics of the persistent cough sub-group, the 
major symptom, were similar for men and women. Age-range was 
recorded for 54 men and 54 women, and the numbers of patients 
in each estimated age group (<30, 30-50, >50 years) was similar 
for both genders. All smokers (25 men; 21 women) were offered 
referral to a smoking cessation service. 
Analysis focused on referral to a GP and supply of an over the 
counter (OTC) product, as either a sole action or in combination 
with others. All patients were entitled to free health care. Results 
showed that more women than men were referred to a GP, and 
more men than women received an OTC product (Table 1). Table 
1 also shows the number of patients for whom those were the only 
actions as well as the Odds Ratio (OR) of the predominant gender 
being predictive of the action taken. 
Table 1: Correlation between patient gender and actions: general medical 
practitioner referral (GP) and supply of over the counter (OTC) products. 
Men
n=52
Women
n=53
Odds Ratio (95% CI)
for predominant gender
Significance
GP referral only 7 19 female; 3.59 (1.36-9.52) p = 0.010*
Total GP referral 17 27 female; 2.14 (0.969-4.72) p = 0.06
OTC supply only 16 9 male; 2.17 (0.859-5.50) p = 0.101
Total OTC supply 28 14 male; 3.25(1.43-7.37) p = 0.0045*
Data only included if both gender and action were recorded. CI represents 
Confidence Interval; *denotes Odds Ratio statistical significance, 
calculated according to Sheskin p542 [3]. 
Conclusion
These findings suggest that even in a pharmacy consultation 
environment, patient gender may be associated with outcome, 
when patients present with symptoms that could indicate lung 
cancer. The difference in outcome suggests men’s uptake of GP 
medical assessment is delayed and this finding is compatible 
with those reported elsewhere. Since patients are partners in the 
decision-making process, this may reflect poorer appreciation by 
men of lung cancer symptoms.
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